4//SEC Filing
T2 Biosystems, Inc. 4
Accession 0000950142-15-002576
CIK 0001492674operating
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:47 PM ET
Size
30.0 KB
Accession
0000950142-15-002576
Insider Transaction Report
Form 4
SCHIFF ANDREW N
10% Owner
Transactions
- Purchase
Common Stock
2015-12-09$9.75/sh+307,692$2,999,997→ 2,830,992 total(indirect: See footnote)
ELMS STEVE
10% Owner
Transactions
- Purchase
Common Stock
2015-12-09$9.75/sh+307,692$2,999,997→ 2,830,992 total(indirect: See footnote)
Purcell Dennis J
10% Owner
Transactions
- Purchase
Common Stock
2015-12-09$9.75/sh+307,692$2,999,997→ 2,830,992 total(indirect: See footnote)
AISLING CAPITAL III LP
10% Owner
Transactions
- Purchase
Common Stock
2015-12-09$9.75/sh+307,692$2,999,997→ 2,830,992 total(indirect: See footnote)
Aisling Capital Partners III LP
10% Owner
Transactions
- Purchase
Common Stock
2015-12-09$9.75/sh+307,692$2,999,997→ 2,830,992 total(indirect: See footnote)
Aisling Capital Partners III LLC
10% Owner
Transactions
- Purchase
Common Stock
2015-12-09$9.75/sh+307,692$2,999,997→ 2,830,992 total(indirect: See footnote)
Footnotes (1)
- [F1]The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP. Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492674
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:47 PM ET
- Size
- 30.0 KB